Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Hepatic insulin gene expression for treatment of IDDM

July 23, 1997

Diabetes: an epidemic for the 21st century

July 23, 1997

Troglitazone clinical data presented at IDF 97

July 23, 1997

Problems of insulin supply: insulin turns 75

July 23, 1997

FINFAT multicenter trial results reported at IDF 97

July 23, 1997

Recombinant infertility drug launched in Canada

July 23, 1997

Economics of diabetes discussed at IDF 97

July 22, 1997

Hyperglycemia increases the risk of cardiovascular disease: epidemiological evidence

July 22, 1997

D1/D2 combination therapy results reported at the 16th IDF congress

July 22, 1997

RPR seeks approval for Menorest in Japan

July 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...